Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
129.78
+2.00 (1.57%)
At close: Mar 13, 2026, 4:00 PM EDT
128.05
-1.73 (-1.33%)
After-hours: Mar 13, 2026, 5:41 PM EDT

Neurocrine Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13,02514,19713,56813,00511,5268,083
Market Cap Growth
11.17%4.64%4.33%12.83%42.60%-9.81%
Enterprise Value
12,01613,13212,94712,23110,6307,812
Last Close Price
129.78141.83136.50131.76119.4485.17
PE Ratio
27.7930.3741.4953.3476.5692.58
Forward PE
16.3115.8718.1521.3422.5324.55
PEG Ratio
0.820.750.310.650.660.37
PS Ratio
4.554.965.766.897.747.13
PB Ratio
3.994.365.245.836.755.88
P/TBV Ratio
4.094.475.475.966.926.07
P/FCF Ratio
17.4018.9624.3535.9635.7034.67
P/OCF Ratio
16.6418.1422.7933.3533.9631.51
EV/Sales Ratio
4.204.595.506.487.146.89
EV/EBITDA Ratio
18.0320.2321.6744.9440.1768.89
EV/EBIT Ratio
18.8821.2122.6948.7542.6976.21
EV/FCF Ratio
16.0517.5423.2433.8332.9233.51
Debt / Equity Ratio
0.130.130.180.120.050.32
Debt / EBITDA Ratio
0.640.640.761.570.993.88
Debt / FCF Ratio
0.560.560.821.190.811.89
Net Debt / Equity Ratio
-0.33-0.33-0.24-0.27-0.42-0.20
Net Debt / EBITDA Ratio
-1.64-1.64-1.04-2.22-2.74-2.39
Net Debt / FCF Ratio
-1.42-1.42-1.11-1.67-2.25-1.16
Asset Turnover
0.690.690.680.670.670.60
Inventory Turnover
0.820.820.711.080.710.49
Quick Ratio
2.922.923.062.252.493.65
Current Ratio
3.393.393.402.452.703.96
Return on Equity (ROE)
16.38%16.38%14.16%12.68%10.03%7.17%
Return on Assets (ROA)
10.06%10.06%11.50%6.71%8.10%4.76%
Return on Invested Capital (ROIC)
18.04%18.04%20.28%13.46%16.60%9.53%
Return on Capital Employed (ROCE)
17.44%17.44%19.65%11.33%13.62%6.07%
Earnings Yield
3.67%3.29%2.41%1.87%1.31%1.08%
FCF Yield
5.75%5.27%4.11%2.78%2.80%2.88%
Buyback Yield / Dilution
0.27%0.27%1.31%-0.50%-0.39%-0.34%
Updated Feb 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q